← Eichor
Study identifier: NCT05983432 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Condition: Non Small Cell Lung Cancer · Lung Cancer · Breast Cancer  ·  Sponsor: SystImmune Inc.

PhasePhase 1
Planned participants470
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Tara Barrineau  ·  425-453-6841  ·  tara.barrineau@systimmune.com

Colandra McDowell  ·  colandra.mcdowell@systimmune.com

Always discuss trial participation with your own doctor first.

Locations (39)

Beverly Hills Cancer CenterBeverly Hills, California, United StatesRecruiting
City of Hope Cancer CenterDuarte, California, United StatesRecruiting
Chao Family Comprehensive Cancer Care and Ambulatory CareIrvine, California, United StatesNot Yet Recruiting
Chao Family Comprehensive Cancer Center and Ambulatory CareIrvine, California, United StatesNot Yet Recruiting
University of California Irvine Medical CenterOrange, California, United StatesRecruiting
UCLA Santa MonicaSanta Monica, California, United StatesRecruiting
University of Colorado Cancer CenterAurora, Colorado, United StatesRecruiting
Yale University, Yale Cancer CenterNew Haven, Connecticut, United StatesRecruiting
Georgetown University Medical CenterWashington D.C., District of Columbia, United StatesRecruiting
Sylvester Comprehensive Cancer CenterMiami, Florida, United StatesRecruiting
Sara Cannon Research Institute Lake NonaOrlando, Florida, United StatesRecruiting
Hematology - Oncology Associates of the Treasure CoastPort Saint Lucie, Florida, United StatesRecruiting

+ 27 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05983432